Viimeisimmät kokeilut

EudraCT Number: 2021-001453-31

Sponsor Protocol Number: CONMED3

Start Date:

Sponsor Name: Copenhagen University Hospital Rigshospitalet

Full Title: Automated pupillometry and NIRS-EEG to detect signatures of consciousness in acute brain injury after apomorphine and methylphenidate stimulation: A placebo-controlled, randomized, cross-over study

Medical condition: We investigate the possible effects of commercially available apomorphine and methylphenidate on signatures of consciousness in patients admitted to the ICU with acute disorder of consciousness, us...

Disease:	Version	SOC Term	Classification Code	Term	Level
	25.1	10029205 - Nervous system disorders	10013509	Disturbances in consciousness NEC	HLT
	21.1	10029205 - Nervous system disorders	10067967	Brain injury	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2007-006044-22

Sponsor Protocol Number: HGT-ELA-038

Start Date:

Sponsor Name: Shire Human Genetic Therapies, Inc. (Shire HGT)

Full Title: A Multi-Center, Open-Label Study Evaluating Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Enzyme Replacement Therapy

Medical condition: Mucopolysaccharidosis Type II (MPS II or Hunter Syndrome)

Disease:	Version	SOC Term	Classification Code	Term	Level
	10.1		10056889		PT

Population Age: Newborns, Infants and toddlers, Children, Under 18

Gender: Male

Trial protocol: PL (Completed)

Trial results: View results

EudraCT Number: 2007-005786-35

Sponsor Protocol Number: DC02RUP/IV/02

Start Date:

Sponsor Name: Uriach Pharma

Full Title: Proof-of-concept, cross over, double blind, placebo-controlled study to assess if Rupatadine 20 mg can improve critical stimulation time thresholds (CSTTs) in patients with acquired cold urticaria

Medical condition: Acquired Cold Urticaria

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10009869	Cold urticaria	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2013-004588-30

Sponsor Protocol Number: TED-C13-003

Start Date:

Sponsor Name: NPS Pharmaceuticals, Inc.

Full Title: A 12-Week Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects Aged 1 Year through 17 Years, with Short Bowel Syndrome who are Dependent on Parenteral Support

Medical condition: Short Bowel Syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
	16.1	10017947 - Gastrointestinal disorders	10049416	Short-bowel syndrome	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: SE (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-001622-24

Sponsor Protocol Number: Spirit Version 12

Start Date:

Sponsor Name: Newcastle Hospital Trust

Full Title: Phase III,multicentre,open-label,prospective randomised trial comparing Imatinib alone at 400mg versus 800mg daily versus Imatinib 400mg daily plus PEG Interferon-alpha with newly diagnosed chronic...

Medical condition: Chronic Myeloid Leukaemia (Chronic Phase)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Completed)

Trial results: (No results available)

EudraCT Number: 2019-002226-79

Sponsor Protocol Number: AUGEAS

Start Date:

Sponsor Name: Region Skåne

Full Title: A 30-day, randomized, evalUator-blind, controlled, multi-centre, parallel Group, phase III study to evaluate the Effect of a Low Maintenance Dose TicAgrelor Regimen versus Standard Dose Clopidogrel...

Medical condition: Coronary Artery Disease (CAD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT
	20.0	10007541 - Cardiac disorders	10072685	Microvascular coronary artery disease	PT
	21.1	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT
	21.1	10042613 - Surgical and medical procedures	10065608	Percutaneous coronary intervention	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Prematurely Ended) IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2005-002180-90

Sponsor Protocol Number: Hypergliom2005

Start Date:

Sponsor Name: Neurologische Uniklinik Regensburg

Full Title: Lókoregionale Tiefenhyperthermie begleitend zu ACNU in der Rezidivtherapie von Patienten mit malignen Gliomen (WHO°III/IV)- Phase I/II-Studie

Medical condition: Recurrent malignant glioma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2006-003934-14

Sponsor Protocol Number: 86,1,2006_06_01

Start Date:

Sponsor Name: Universitätsmedizin Göttingen

Full Title: „Eine randomisierte, placebokontrollierte Doppelblindstudie zur Evaluation der Effektivität oral verabreichten Doxycyclins bei Patienten mit Creutzfeldt-Jakob-Krankheit“

Medical condition: Creutzfeldt-Jakob-Krankheit

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10021881 - Infections and infestations	10055172	Creutzfeld-Jakob disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004443-22

Sponsor Protocol Number: Spirig I 04-05

Start Date:

Sponsor Name: Spirig Pharma AG

Full Title: Untersuchung der Wirksamkeit einer glycerinhaltigen Creme bei der Behandlung von Atopischer Dermatitis. Kontrolliert, randomisierte Doppel-Blind-Studie.

Medical condition: Atopic Dermatitis

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10012438

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2017-001550-34

Sponsor Protocol Number: TIGEM2-PDH

Start Date:

Sponsor Name: FONDAZIONE TELETHON

Full Title: Studio clinico pilota per valutare l’efficacia della terapia con fenilbutirrato in pazienti affetti da deficit di piruvato deidrogenasi

Medical condition: La Sperimentazione verrà eseguita su pazienti affetti da difetto dell’enzima piruvato deidrogenasi.I pazienti affetti da questa malattia manifestano aumento dei livelli di lattato nel sangue e nell...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10027433 - Metabolism and nutrition disorders	10058097	Metabolic disorder	PT
	20.1	10027433 - Metabolism and nutrition disorders	10000491	Acidosis lactic	LLT
	20.0	10022891 - Investigations	10037677	Pyruvate	LLT
	20.0	10022891 - Investigations	10023660	Lactate increased	LLT
20.0	10022891 - Investigations	10057975	Lactate pyruvate ratio	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

Viimeisimmät kokeilut

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot